🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
Primary Objectives: Phase 1 -To characterize the safety and tolerability ...
Status
Terminated
Location
Investigational Site Number :2500005
Start Date
2018-12-11
Trial ID
NCT03769181
Treatments Being Tested
The primary purpose of this study is to assess the efficacy (overall respon...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Start Date
2025-03-17
Trial ID
NCT06356571
This is a multi-center, open label, phase II study designed to evaluate the...
Status
Active Not Recruiting
Location
Mount Sinai Hospital
Start Date
2017-02-08
Trial ID
NCT02960555
Treatments Being Tested
Primary Objectives: * Phase 1: To characterize the safety and tolerability...
Status
Terminated
Location
Investigational Site Number :8400003
Start Date
2020-06-18
Trial ID
NCT04294459
Primary Objectives: * Safety run-in Part: To confirm the recommended dose ...
Status
Active Not Recruiting
Location
UCLA Site Number : 8400010
Start Date
2020-06-16
Trial ID
NCT04270409
This phase Ib trial studies the side effects and best dose of isatuximab wh...
Status
Completed
Location
University of California, San Francisco
Start Date
2015-01-21
Trial ID
NCT02332850
Treatments Being Tested
This phase I trial tests the side effects and best dose of TGFbi natural ki...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-03-05
Trial ID
NCT06203912
This phase II trial studies how well isatuximab works in treating patients ...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-06-06
Trial ID
NCT03499808
Treatments Being Tested
This is a randomized, multicenter, Phase 3, open-label study evaluating sub...
Status
Active Not Recruiting
Location
Mohtaseb Cancer Center and Blood Disorders Site Number : 8400028
Start Date
2022-06-23
Trial ID
NCT05405166